UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by 180 Wealth Advisors LLC

180 Wealth Advisors LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,960 shares of the healthcare conglomerate’s stock after selling 50 shares during the period. 180 Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,370,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Moneta Group Investment Advisors LLC boosted its position in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $5,210,004,000. Gateway Advisory LLC lifted its position in UnitedHealth Group by 48,406.9% during the 1st quarter. Gateway Advisory LLC now owns 4,762,407 shares of the healthcare conglomerate’s stock worth $4,762,000 after acquiring an additional 4,752,589 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of UnitedHealth Group by 264.2% during the first quarter. Envestnet Asset Management Inc. now owns 5,511,174 shares of the healthcare conglomerate’s stock valued at $732,934,000 after purchasing an additional 3,997,959 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the period. 85.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their target price for the company from $595.00 to $603.00 in a research note on Tuesday, July 18th. Piper Sandler initiated coverage on shares of UnitedHealth Group in a report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price target on the stock. HSBC initiated coverage on shares of UnitedHealth Group in a research report on Wednesday, September 6th. They issued a “hold” rating and a $540.00 target price for the company. Morgan Stanley reaffirmed an “overweight” rating and issued a $587.00 price objective on shares of UnitedHealth Group in a report on Friday, July 14th. Finally, JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a report on Monday, July 17th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $575.65.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH stock opened at $486.06 on Tuesday. The firm’s fifty day simple moving average is $492.05 and its 200 day simple moving average is $486.73. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a price-to-earnings-growth ratio of 1.43 and a beta of 0.66. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. The firm had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The business’s revenue was up 15.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.57 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a dividend of $1.88 per share. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.

Insiders Place Their Bets

In related news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares in the company, valued at approximately $39,772,866.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.